Benzodiazepines share a similar chemical structure, and their effects in humans are mainly produced by the allosteric modification of a specific kind of neurotransmitter receptor, the GABAA receptor, which increases the overall conductance of these inhibitory channels; this results in the various therapeutic effects as well as adverse effects of benzodiazepines.
Benzodiazepines have similar chemical structures and their effects on humans are primarily due to allosteric modulation of a specific type of neurotransmitter receptor, the GABAA receptor, which enhances the flow of inhibitory signals; this leads to both therapeutic benefits and adverse reactions associated with benzodiazepines.